Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1972 May 6;2(5809):337–341. doi: 10.1136/bmj.2.5809.337

Hyperthyroidism.

P Kendall-Taylor
PMCID: PMC1788222  PMID: 4112238

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARANOW H., Jr, DAY R. M. MANAGEMENT OF THYROTOXICOSIS IN PATIENTS WITH OPHTHALMOPATHY: ANTITHYROID REGIMEN DETERMINED PRIMARILY BY OCULAR MANIFESTATIONS. J Clin Endocrinol Metab. 1965 Jan;25:1–10. doi: 10.1210/jcem-25-1-1. [DOI] [PubMed] [Google Scholar]
  2. Acland J. D. The interpretation of the serum protein-bound iodine: A review. J Clin Pathol. 1971 Apr;24(3):187–218. doi: 10.1136/jcp.24.3.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CROOKS J., MURRAY I. P., WAYNE E. J. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Q J Med. 1959 Apr;28(110):211–234. [PubMed] [Google Scholar]
  4. Chan V., Landon J. Urinary thyroxine excretion as index of thyroid function. Lancet. 1972 Jan 1;1(7740):4–6. doi: 10.1016/s0140-6736(72)90002-5. [DOI] [PubMed] [Google Scholar]
  5. Connolly R. J., Vidor G. I., Stewart J. C. Increase in thyrotoxicosis in endemic goitre area after iodation of bread. Lancet. 1970 Mar 7;1(7645):500–502. doi: 10.1016/s0140-6736(70)91582-5. [DOI] [PubMed] [Google Scholar]
  6. Das G., Krieger M. Treatment of thyrotoxic storm with intravenous administration of propranolol. Ann Intern Med. 1969 May;70(5):985–988. doi: 10.7326/0003-4819-70-5-985. [DOI] [PubMed] [Google Scholar]
  7. EKINS R. P. The estimation of thyroxine in human plasma by an electrophoretic technique. Clin Chim Acta. 1960 Jul;5:453–459. doi: 10.1016/0009-8981(60)90051-6. [DOI] [PubMed] [Google Scholar]
  8. Ensor J. M., Kendall-Taylor P., Munro D. S., Smith B. R. The bioassay of long-acting thyroid stimulator: a comparison of two methods. J Endocrinol. 1971 Mar;49(3):487–492. doi: 10.1677/joe.0.0490487. [DOI] [PubMed] [Google Scholar]
  9. Goolden A. W., Gartside J. M., Sanderson C. Thyroid status in pregnancy and in women taking oral contraceptives. Lancet. 1967 Jan 7;1(7480):12–15. doi: 10.1016/s0140-6736(67)92420-8. [DOI] [PubMed] [Google Scholar]
  10. Gurney C., Hall R., Harper M., Owen S. G., Roth M., Smart G. A. Newcastle thyrotoxicosis index. Lancet. 1970 Dec 19;2(7686):1275–1278. doi: 10.1016/s0140-6736(70)92241-5. [DOI] [PubMed] [Google Scholar]
  11. Hadden D. R., Bell T. K., McDevitt D. G., Shanks R. G., Montgomery D. A., Weaver J. A. Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol (Copenh) 1969 Jul;61(3):393–399. doi: 10.1530/acta.0.0610393. [DOI] [PubMed] [Google Scholar]
  12. Hadden D. R., Montgomery D. A., Shanks R. G., Weaver J. A. Propranolol and iodine-131 in the management of thyrotoxicosis. Lancet. 1968 Oct 19;2(7573):852–854. doi: 10.1016/s0140-6736(68)91003-9. [DOI] [PubMed] [Google Scholar]
  13. Harden R. M., Alexander W. D., Koutras D. A., Harrison M. T., Wayne E. Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs. J Clin Endocrinol Metab. 1966 Apr;26(4):397–401. doi: 10.1210/jcem-26-4-397. [DOI] [PubMed] [Google Scholar]
  14. Hedley A. J., Flemming C. J., Chesters M. I., Michie W., Crooks J. Surgical treatment of thyrotoxicosis. Br Med J. 1970 Feb 28;1(5695):519–523. doi: 10.1136/bmj.1.5695.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hershman J. M., Givens J. R., Cassidy C. E., Astwood E. B. Long-term outcome of hyperthyroidism treated with antithyroid drugs. J Clin Endocrinol Metab. 1966 Aug;26(8):803–807. doi: 10.1210/jcem-26-8-803. [DOI] [PubMed] [Google Scholar]
  16. Hershman J. M., Higgins H. P. Hydatidiform mole--a cause of clinical hyperthyroidism. Report of two cases with evidence that the molar tissue secreted a thyroid stimulator. N Engl J Med. 1971 Mar 18;284(11):573–577. doi: 10.1056/NEJM197103182841103. [DOI] [PubMed] [Google Scholar]
  17. Howorth P. J., Maclagan N. F. Clinical application of serum-total-thyroxine estimation, resin uptake, and free-thyroxine index. Lancet. 1969 Feb 1;1(7588):224–228. doi: 10.1016/s0140-6736(69)91240-9. [DOI] [PubMed] [Google Scholar]
  18. Kriss J. The nature and significance of the long-acting thyroid stimulator. Adv Metab Disord. 1968;3:209–230. doi: 10.1016/b978-1-4831-9943-6.50012-8. [DOI] [PubMed] [Google Scholar]
  19. MCKENZIE J. M. NEONATAL GRAVES' DISEASE. J Clin Endocrinol Metab. 1964 Jul;24:660–668. doi: 10.1210/jcem-24-7-660. [DOI] [PubMed] [Google Scholar]
  20. McDougall I. R., Greig W. R., Gillespie F. C. Radioactive iodine (125I) therapy for thyrotoxicosis. N Engl J Med. 1971 Nov;285(20):1099–1104. doi: 10.1056/NEJM197111112852001. [DOI] [PubMed] [Google Scholar]
  21. McDougall I. R., Kennedy J. S., Thomson J. A. Thyroid carcinoma following iodine-131 therapy. Report of a case and review of the literature. J Clin Endocrinol Metab. 1971 Aug;33(2):287–292. doi: 10.1210/jcem-33-2-287. [DOI] [PubMed] [Google Scholar]
  22. McKENZIE J. M. The bioassay of thyrotropin in serum. Endocrinology. 1958 Sep;63(3):372–382. doi: 10.1210/endo-63-3-372. [DOI] [PubMed] [Google Scholar]
  23. Michie W., Pegg C. A., Bewsher P. D. Prediction of hypothyroidism after partial thyroidectomy for thyrotoxicosis. Br Med J. 1972 Jan 1;1(5791):13–17. doi: 10.1136/bmj.1.5791.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nofal M. M., Beierwaltes W. H., Patno M. E. Treatment of hyperthyroidism with sodium iodide I-131. JAMA. 1966 Aug 22;197(8):605–610. [PubMed] [Google Scholar]
  25. POCHIN E. E. Leukaemia following radioiodine treatment of thyrotoxicosis. Br Med J. 1960 Nov 26;2(5212):1545–1550. doi: 10.1136/bmj.2.5212.1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Saenger E. L., Thoma G. E., Tompkins E. A. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA. 1968 Sep 16;205(12):855–862. [PubMed] [Google Scholar]
  27. Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. Controlled trial of propranolol in thyrotoxicosis. Lancet. 1969 May 17;1(7603):993–994. doi: 10.1016/s0140-6736(69)91797-8. [DOI] [PubMed] [Google Scholar]
  28. Smith R. N., Wilson G. M. Clinical trial of different doses of 131-I in treatment of thyrotoxicosis. Br Med J. 1967 Jan 21;1(5533):129–132. doi: 10.1136/bmj.1.5533.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sterling K., Bellabarba D., Newman E. S., Brenner M. A. Determination of triiodothyronine concentration in human serum. J Clin Invest. 1969 Jun;48(6):1150–1158. doi: 10.1172/JCI106072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sterling K., Brenner M. A. Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation. J Clin Invest. 1966 Jan;45(1):153–163. doi: 10.1172/JCI105320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sterling K., Refetoff S., Selenkow H. A. T3 thyrotoxicosis. Thyrotoxicosis due to elevated serum triiodothyronine levels. JAMA. 1970 Jul 27;213(4):571–575. doi: 10.1001/jama.213.4.571. [DOI] [PubMed] [Google Scholar]
  32. Turner P., Granville-Grossman K. L. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet. 1965 Dec 25;2(7426):1316–1318. doi: 10.1016/s0140-6736(65)92340-8. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES